Sarah R. Vaiselbuh

493 total citations
19 papers, 339 citations indexed

About

Sarah R. Vaiselbuh is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Sarah R. Vaiselbuh has authored 19 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Sarah R. Vaiselbuh's work include Extracellular vesicles in disease (6 papers), MicroRNA in disease regulation (5 papers) and Histiocytic Disorders and Treatments (4 papers). Sarah R. Vaiselbuh is often cited by papers focused on Extracellular vesicles in disease (6 papers), MicroRNA in disease regulation (5 papers) and Histiocytic Disorders and Treatments (4 papers). Sarah R. Vaiselbuh collaborates with scholars based in United States, Canada and Sweden. Sarah R. Vaiselbuh's co-authors include Shabirul Haque, Carl E. Allen, James A. Whitlock, Oussama Abla, Yenan T. Bryceson, Jeffrey M. Lipton, Morris Edelman, Johnson M. Liu, Joanna Pierro and Michael B. Jordan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancers.

In The Last Decade

Sarah R. Vaiselbuh

18 papers receiving 336 citations

Peers

Sarah R. Vaiselbuh

IMMUN

PHYSI

HEMAT

Pascale Blouin France

Alexandra Kolenová Slovakia

Hee Jo Baek South Korea

Maoquan Qin China

Musa Alharbi Saudi Arabia

Maxine Hetherington United States

Kristen White United States

Lisa Madden United States

Yoshinari Kawabata Japan

Muriel Picard France

Pascale Blouin France

Sarah R. Vaiselbuh

122 ×1.1

26 ×0.3

IMMUN

51 ×0.6

PHYSI

34 ×0.4

HEMAT

40 ×0.5

Citations per year, relative to Sarah R. Vaiselbuh Sarah R. Vaiselbuh (= 1×) peers Pascale Blouin

Countries citing papers authored by Sarah R. Vaiselbuh

Since Specialization

Citations

This map shows the geographic impact of Sarah R. Vaiselbuh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah R. Vaiselbuh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah R. Vaiselbuh more than expected).

Fields of papers citing papers by Sarah R. Vaiselbuh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah R. Vaiselbuh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah R. Vaiselbuh. The network helps show where Sarah R. Vaiselbuh may publish in the future.

Co-authorship network of co-authors of Sarah R. Vaiselbuh

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah R. Vaiselbuh. A scholar is included among the top collaborators of Sarah R. Vaiselbuh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah R. Vaiselbuh. Sarah R. Vaiselbuh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Haque, Shabirul & Sarah R. Vaiselbuh. (2021). Exosomal DNMT1 mRNA transcript is elevated in acute lymphoblastic leukemia which might reprograms leukemia progression. Cancer Genetics. 260-261. 57–64. 9 indexed citations

Haque, Shabirul & Sarah R. Vaiselbuh. (2021). CD19 Chimeric Antigen Receptor-Exosome Targets CD19 Positive B-lineage Acute Lymphocytic Leukemia and Induces Cytotoxicity. Cancers. 13(6). 1401–1401. 50 indexed citations

Haque, Shabirul & Sarah R. Vaiselbuh. (2020). Vincristine and prednisone regulates cellular and exosomal miR-181a expression differently within the first time diagnosed and the relapsed leukemia B cells. Leukemia Research Reports. 14. 100221–100221. 8 indexed citations

Terjanian, Terenig, et al.. (2020). Clinical trial awareness in oncology patients of diverse ethnic background: A single-institution analysis.. Journal of Clinical Oncology. 38(15_suppl). e19217–e19217. 1 indexed citations

Haque, Shabirul & Sarah R. Vaiselbuh. (2020). Silencing of Exosomal miR-181a Reverses Pediatric Acute Lymphocytic Leukemia Cell Proliferation. Pharmaceuticals. 13(9). 241–241. 31 indexed citations

Haque, Shabirul & Sarah R. Vaiselbuh. (2018). Exosomes molecular diagnostics: Direct conversion of exosomes into the cDNA for gene amplification by two-step polymerase chain reaction. Journal of Biological Methods. 5(3). 1–1. 10 indexed citations

Vaiselbuh, Sarah R., et al.. (2016). A unique case of Shwachman-Diamond syndrome presenting with congenital hypopituitarism. Journal of Pediatric Endocrinology and Metabolism. 0(0). 1325–1327. 5 indexed citations

Haque, Shabirul & Sarah R. Vaiselbuh. (2016). Leukemia-Derived Exosomes Induce Paracrine and Autocrine Cell Proliferation in Pediatric ALL. Blood. 128(22). 4080–4080. 6 indexed citations

Cacciotti, Chantel, et al.. (2016). Visual Diagnosis: Periorbital Edema in a 7-year-old Girl. Pediatrics in Review. 37(3). e7–e9.

10.

Zweidler‐McKay, Patrick A., Rima Jubran, Jacqueline Casillas, et al.. (2016). Navigating your career path in pediatric hematology/oncology: On and off the beaten track. Pediatric Blood & Cancer. 63(10). 1723–1730. 6 indexed citations

11.

Cacciotti, Chantel, et al.. (2016). Pain Management for Sickle Cell Disease in the Pediatric Emergency Department: Medications and Hospitalization Trends. Clinical Pediatrics. 56(12). 1109–1114. 15 indexed citations

12.

Badawy, Sherif M., Emily Riehm Meier, Kasiani C. Myers, et al.. (2016). Early career mentoring through the American Society of Pediatric Hematology/Oncology: Lessons learned from a pilot program. Pediatric Blood & Cancer. 64(3). 18 indexed citations

13.

Arceci, R.J., Carl E. Allen, Ira J. Dunkel, et al.. (2016). A phase IIa study of afuresertib, an oral pan‐AKT inhibitor, in patients with Langerhans cell histiocytosis. Pediatric Blood & Cancer. 64(5). 15 indexed citations

14.

Marsh, Rebecca, Michael B. Jordan, Julie‐An Talano, et al.. (2016). Salvage therapy for refractory hemophagocytic lymphohistiocytosis: A review of the published experience. Pediatric Blood & Cancer. 64(4). e26308–e26308. 37 indexed citations

15.

Vaiselbuh, Sarah R.. (2015). Exosomes in Cancer Research. 1(1). 11–24. 6 indexed citations

16.

Vaiselbuh, Sarah R., Yenan T. Bryceson, Carl E. Allen, James A. Whitlock, & Oussama Abla. (2014). Updates on histiocytic disorders. Pediatric Blood & Cancer. 61(7). 1329–1335. 65 indexed citations

17.

Pierro, Joanna & Sarah R. Vaiselbuh. (2014). Adult Langerhans Cell Histiocytosis As a Diagnostic Pitfall. Journal of Clinical Oncology. 34(6). e41–e45. 11 indexed citations

18.

Frugé, Ernest, Joan M. Lakoski, Naomi L.C. Luban, et al.. (2011). Increasing diversity in pediatric hematology/oncology. Pediatric Blood & Cancer. 57(1). 147–152. 12 indexed citations

19.

Vaiselbuh, Sarah R., Morris Edelman, Jeffrey M. Lipton, & Johnson M. Liu. (2010). Ectopic Human Mesenchymal Stem Cell-Coated Scaffolds in NOD/SCID Mice: An In Vivo Model of the Leukemia Niche. Tissue Engineering Part C Methods. 16(6). 1523–1531. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact